Table 2.
Post-transplanted stable group (n = 15) | Post-transplanted AR group (n = 15) | Healthy group (n = 15) | |
CD4/CD8 | 1.5±0.5 | 1.8±0.4 | 1.5±0.2 |
CD16+56+ (%) | 15.4±9.5 | 20.4±9.4 | 17.0±7.5 |
Post-transplanted stable group (n = 15) | Post-transplanted AR group (n = 15) | Healthy group (n = 15) | |
CD4/CD8 | 1.5±0.5 | 1.8±0.4 | 1.5±0.2 |
CD16+56+ (%) | 15.4±9.5 | 20.4±9.4 | 17.0±7.5 |